GBR 12909 Study in Cocaine Experienced African American Volunteers - 1
Phase 1
- Conditions
- Cocaine-Related Disorders
- Registration Number
- NCT00089687
- Lead Sponsor
- National Institute on Drug Abuse (NIDA)
- Brief Summary
The purpose of this study is to assess GBR 12909 in cocaine experienced African American Volunteers.
- Detailed Description
Double-blind, placebo-controlled, safety and pharmacology study with 75 mg dosage of GBR 12909 in cocaine experienced African American Volunteers. Particular interest is being given to the hematological safety data.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
- Must be within 20% of ideal body weight and must weigh at least 45 kg.
- Must understand the study procedures and provide written informed consent.
- Must meet DSM-4 criteria for abuse or dependence on cocaine.
- Must be non-treatment seeking at the time of the study.
Exclusion Criteria
- Please contact the study site for more information.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method pharmacokinetic assessment
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Uniformed Services University of Health Science
🇺🇸Bethesda, Maryland, United States